Brain Imaging and Pain in Irritable Bowel Syndrome

This study has been completed.

First Received on July 31, 2003. Last Updated on September 16, 2011 History of Changes

Sponsor:	University of Florida
Collaborators:	National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):	University of Florida
ClinicalTrials.gov Identifier:	NCT00065754

Purpose

This study examines the mechanisms, including brain imaging of placebo analgesia

Condition	Intervention
Irritable Bowel Syndrome	Drug: placebo

Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Factorial Assignment Masking: Double-Blind
Official Title:	Brain Imaging and Pain: Analysis of Placebo Analgesia

Further study details as provided by University of Florida:

Estimated Enrollment:	50
Study Start Date:	September 2003
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Eligibility

Criteria

Inclusion criteria:

Exclusion criteria:

Chronic pain condition other than Irritable Bowel Syndrome
Medical condition that would contraindicate use of lidocaine
Clinical criteria for fibromyalgia
Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
Seropositive HIV
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065754

Locations

United States, Florida
University of Florida
Gainesville, Florida, United States, 32610

Sponsors and Collaborators

University of Florida

Investigators

Principal Investigator:

Michael E Robinson, PhD

University of Florida

More Information

No publications provided

Responsible Party:	University of Florida
ClinicalTrials.gov Identifier:	NCT00065754 History of Changes
Other Study ID Numbers:	R01 AT001424-01, R01AT001424-01
Study First Received:	July 31, 2003
Last Updated:	September 16, 2011
Health Authority:	United States: Federal Government

Keywords provided by University of Florida:

Placebo
Analgesia
Pain
Brain mechanism
Expectation

Additional relevant MeSH terms:

Irritable Bowel Syndrome
Colonic Diseases, Functional
Colonic Diseases

Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on February 09, 2012